- Home
- LIEN vs OSUR Comparison
LIEN vs OSUR Comparison
Compare LIEN & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIEN
- OSUR
- Stock Information
- Founded
- LIEN 2021
- OSUR 2000
- Country
- LIEN United States
- OSUR United States
- Employees
- LIEN N/A
- OSUR N/A
- Industry
- LIEN
- OSUR Medical/Dental Instruments
- Sector
- LIEN
- OSUR Health Care
- Exchange
- LIEN NYSE
- OSUR Nasdaq
- Market Cap
- LIEN 254.2M
- OSUR 223.0M
- IPO Year
- LIEN 2022
- OSUR 1986
- Fundamental
- Price
- LIEN $10.35
- OSUR $2.86
- Analyst Decision
- LIEN
- OSUR Hold
- Analyst Count
- LIEN 0
- OSUR 2
- Target Price
- LIEN N/A
- OSUR $5.50
- AVG Volume (30 Days)
- LIEN 17.4K
- OSUR 726.8K
- Earning Date
- LIEN 05-08-2025
- OSUR 05-07-2025
- Dividend Yield
- LIEN 13.60%
- OSUR N/A
- EPS Growth
- LIEN N/A
- OSUR N/A
- EPS
- LIEN 0.93
- OSUR N/A
- Revenue
- LIEN $21,665,753.00
- OSUR $185,827,000.00
- Revenue This Year
- LIEN $102.44
- OSUR N/A
- Revenue Next Year
- LIEN N/A
- OSUR $7.55
- P/E Ratio
- LIEN $11.28
- OSUR N/A
- Revenue Growth
- LIEN 81.56
- OSUR N/A
- 52 Week Low
- LIEN $9.71
- OSUR $2.69
- 52 Week High
- LIEN $13.38
- OSUR $5.59
- Technical
- Relative Strength Index (RSI)
- LIEN N/A
- OSUR 36.89
- Support Level
- LIEN N/A
- OSUR $2.85
- Resistance Level
- LIEN N/A
- OSUR $3.01
- Average True Range (ATR)
- LIEN 0.00
- OSUR 0.15
- MACD
- LIEN 0.00
- OSUR -0.01
- Stochastic Oscillator
- LIEN 0.00
- OSUR 0.94
About LIEN CHICAGO ATLANTIC BDC INC
Chicago Atlantic BDC Inc is a specialty finance company. The company is an externally managed, closed-end, non-diversified management investment company with an investment objective to maximize risk-adjusted returns on equity for its stockholders by investing in direct loans to privately held middle-market companies, with a focus on cannabis companies.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.